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Abstract
Protein aggregation and abnormal lipid homeostasis are both implicated in neurodegeneration through unknown
mechanisms. Here we demonstrate that aggregate-membrane interaction is critical to induce a form of cell death called
ferroptosis. Importantly, the aggregate-membrane interaction that drives ferroptosis depends both on the conformational
structure of the aggregate, as well as the oxidation state of the lipid membrane. We generated human stem cell-derived
models of synucleinopathy, characterized by the intracellular formation of α-synuclein aggregates that bind to membranes.
In human iPSC-derived neurons with SNCA triplication, physiological concentrations of glutamate and dopamine induce
abnormal calcium signaling owing to the incorporation of excess α-synuclein oligomers into membranes, leading to altered
membrane conductance and abnormal calcium influx. α-synuclein oligomers further induce lipid peroxidation. Targeted
inhibition of lipid peroxidation prevents the aggregate-membrane interaction, abolishes aberrant calcium fluxes, and restores
physiological calcium signaling. Inhibition of lipid peroxidation, and reduction of iron-dependent accumulation of free
radicals, further prevents oligomer-induced toxicity in human neurons. In summary, we report that peroxidation of
polyunsaturated fatty acids underlies the incorporation of β-sheet-rich aggregates into the membranes, and that additionally
induces neuronal death. This suggests a role for ferroptosis in Parkinson’s disease, and highlights a new mechanism by
which lipid peroxidation causes cell death.
Introduction
Synucleinopathies are neurodegenerative diseases that are
characterized by the abnormal aggregation of the protein
α-synuclein, and include Dementia with Lewy Body dis-
ease, Parkinson’s disease (PD), and multiple system
atrophy [1]. Within this group of diseases, it is evident
that α-synuclein aggregation, or Lewy Body pathology,
occurs in diverse cell groups including the enteric nervous
system, midbrain dopaminergic neurons and cortical
neurons [2–5]. Genetic evidence shows that alteration in
the concentration or structure of α-synuclein causes the
synucleinopathies, in particular PD. Missense mutations,
and duplications or triplications of the SNCA gene, lead
to autosomal dominant PD [6–9] that is indistinguishable
from sporadic PD, apart from early onset and a more
aggressive course. Variations in the SNCA gene that lead
to increased α-synuclein expression represent a genetic
risk factor for sporadic PD [10].
These authors contributed equally: Plamena R. Angelova, Minee
L. Choi
These authors jointly supervised this work: Andrey Y. Abramov,
Sonia Gandhi
Edited by A. Degterev
* Andrey Y. Abramov
a.abramov@ucl.ac.uk
* Sonia Gandhi
sonia.gandhi@ucl.ac.uk
Extended author information available on the last page of the article
Supplementary information The online version of this article (https://
doi.org/10.1038/s41418-020-0542-z) contains supplementary material,
which is available to authorized users.
12
34
56
78
90
()
;,:
12
34
56
78
90
();
,:
Compelling pathological and genetic data defines α-
synuclein as the cause of synucleinopathies, and raises the
question of how aggregation induces cellular dysfunction
and death. During aggregation, α-synuclein transitions from
an intrinsically disordered monomeric protein to form small
soluble oligomers with increasing β-sheet content, followed
by protofibrils and insoluble fibrils. The soluble inter-
mediate oligomeric species of α-synuclein may be ‘toxic’ to
cells, and the toxicity of certain oligomers of α-synuclein
may be attributed to specific structural characteristics that
confer damaging properties [11]. It is well established that
α-synuclein interacts with lipids in its monomeric form,
where it may regulate synaptic vesicle trafficking [12].
Importantly, oligomers of high β-sheet content and exposed
hydrophobic residues also interact with lipids, and disrupt
or damage membrane structure, resulting in aberrant ion
fluxes [13–15]. We have also demonstrated that oligomeric
species can generate reactive oxygen species within the cell,
and this leads to the oxidation of lipids in the plasmalemmal
and mitochondrial membranes, as well as oxidation of
mitochondrial proteins [13, 16, 17]. Oligomer-induced
oxidation events open the mitochondrial permeability tran-
sition pore, leading to apoptosis [18]. However, other forms
of cell death also exist, and death by ‘ferroptosis’ has
emerged to describe cell toxicity driven by the iron-
dependent accumulation of lipid peroxides [19].
In this study, we utilized two human stem cell-derived
models of synucleinopathy to investigate how protein
aggregation, calcium signaling, and redox biology interact
to induce toxicity. We investigate (i) the effect of cellular
uptake of exogenously applied recombinant oligomers, in
which we can control the structure and concentration of the
species and (ii) the effect of longer term endogenous
increased expression of α-synuclein from SNCA mutations,
and therefore the consequence of endogenously generated
oligomeric species. α-synuclein aggregation occurs in
human neurons, and these aggregates deregulate physiolo-
gical calcium signaling, an effect dependent on the inter-
action between aggregates and membranes. Importantly
modulation of the oxidation state of the lipids changes the
membrane—α-synuclein interactions, and cell viability,
highlighting the cell death pathway, ferroptosis, in these
models.
Material and methods
Human stem cell-derived models
Human induced pluripotent stem cell (iPSC) culture
iPSCs were derived from donors who had given signed
informed consent for derivation of iPSC lines from skin
biopsies as part of the EU IMI-funded program Stem-
BANCC. All experimental protocols had approval from the
London—Hampstead Research Ethics Committee (ref: 13/
13/LO/0171, IRAS project ID: 100318) and R&D approval
from the University College London Great Ormond Street
Institute of Child Health and Great Ormond Street Hospital
Join Research Office.
iPSC-derived cortical neurons from three SNCA tripli-
cation (SNCA x3) clones and three control clones were
generated using standard protocols, and all experiments
were performed on a minimum of three independent
inductions. Experiments were repeated using the SNCA x3
clones, and an isogenic clone generated from the same
patient. iPSCs were generated from a patient with early
onset autosomal dominant PD owing to a triplication of the
SNCA gene (encoding α-synuclein) using viral transduction
of OCT4, SOX2, KLF4 and c-MYC [20]. SNCA x3 results
in four copies of the SNCA gene, and a doubling of SNCA
mRNA and α-synuclein protein. CRISPR/Cas9 nickase
technology was employed to remove two SNCA alleles to
restore the SNCA gene dosage to two copies, whilst
retaining the rest of the triplication locus (that is, the iso-
genic control, [21]. The isogenic cell line was generated
from a SNCA x3 iPSC clone by CRISPR/Cas9 double
nickase gene editing to knockout two SNCA alleles, redu-
cing the allele dosage from four (in the triplication cells) to
two (normal). This method retains the rest of the triplication
locus intact, and therefore provides the ideal control for the
effects of SNCA x3 alone.
iPSCs were cultured on Geltrex (Thermo-Fisher) in
Essential eight medium (Thermo-Fisher) and passaged
using 0.5 mM EDTA (Thermo-Fisher). Neural induction was
performed through dual SMAD inhibition using SB431542
(10 µM, Tocris) and dorsomorphin dihydrochloride (1 µM
Tocris) within N2B27 media—DMEM;F12+ glutamax,
neurobasal, B28, N2, glutamax, insulin, non-essential
amino acids, 2-mercaptoethanol, Pen/strep- (modified
from ref. [22]). Cells were first passaged with dispase
(Thermo-Fisher, 1:2) at day 10 upon first appearance of the
neuroepithelial sheet. Upon appearance of neural rosettes at
day 20–21, cells are passaged again with dispase. Cells
were passaged approximately three more times before being
used at day 70–90. All lines were mycoplasma tested (all
negative) and performed with short tandem repeat profiling
(all matched) by the Francis Crick Institute Cell
service team.
Human embryonic stem (ES) cells culture
The hESC line was kindly provided by Dr. David Hay
(University of Edinburgh), upon MRC Steering Committee
approval (ref. no. SCSC11-60). The line was established at
the Centre for Stem Cell Biology (University of Sheffield)
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under a license from the Human Fertilization and Embry-
ology Authority, and has been validated to show the stan-
dard hESC characteristics including a normal karyotype. In
brief, pCAG-SNCA-IRES-Venus or the control pCAG-IV
were transfected into hES cells followed by antibiotic
selection to allow the generation of clones with stable
expression of SNCA. Clones exhibiting normal morphol-
ogy, growth and differentiation behavior were selected and
characterized for SNCA expression, and two clones with
near normal levels of SNCA expression (here designated
control) and high levels of SNCA expression (designated as
hES OE syn) were utilized for further studies.
For neural induction, hES cells were dissociated into
single cells with Accutase (Gibco, Cat. no. A11105-01) and
plated on a Matrigel-coated six-well plate in mTeSR1
medium. Cells were fed daily until they reached 90%
confluency or above. Neural induction started at day 0,
when mTeSR1 was replaced with hESC medium lacking
FGF2, supplemented with 10 μM SB431542 (Tocris) and
100 nM LDN-193189 (Stemgent). Cells were fed daily with
this medium until day 4. From day 5 to day 11, SB431542
was withdrawn and cells were fed every other day with a
mixture of hESC medium and N2B27, which was gradually
added into culture medium from 25%, 50%, 75%, and
100% at day 5, day 7, day 9, and day 11, respectively.
pCAG-SNCA-IRES-Venus or the control pCAG-IV were
transfected into hES cells followed by antibiotic selection to
allow the generation of clones with stable expression of
SNCA. Clones exhibiting normal morphology, growth and
differentiation behavior were selected and characterized for
SNCA expression, and two clones with near normal levels
of SNCA expression (here designated control) and high
levels of SNCA expression (designated as hES OE syn)
were utilized for further studies.
Aggregation of α-synuclein
Wild-type α-synuclein and A90C variant were purified from
Escherichia coli as previously described by Hoyer et al.
[23]. All α-synuclein aggregations (using labeled or unla-
beled protein) were conducted in LoBind microcentrifuge
tubes (Eppendorf) to limit surface adsorption.
For the aggregation reactions of unlabeled recombinant
α-synuclein, a 70 μM solution of wild-type α-synuclein in
25 mM Tris buffer with 100 mM NaCl pH 7.4 (supplemented
with 0.01% NaN3 to prevent bacterial growth during
aggregation) was incubated at 37 °C with constant agitation
at 200 rpm (New Brunswick Scientific Innova 43), during
which time aliquots were taken.
For the aggregation reactions of labeled α-synuclein, the
A90C variant of monomeric α-synuclein was labeled with
maleimide-linked Alexa Fluor 488 (AF488) or Alexa Fluor
594 (AF594) (Life Technologies) as described previously
[16, 24]. The excess dye was removed by passing the
labeled protein through a P10 desalting column containing
Sephadex G25 matrix (GE Healthcare, Waukesha, WI).
After elution, protein concentration was determined using a
nanodrop and the sample divided into aliquots, before being
flash-frozen in liquid nitrogen and stored at −80 °C. Each
aliquot was only thawed once prior to use. AF488-labeled
and AF594-labeled monomeric α-synuclein were diluted in
Tris buffer (same composition as mentioned above) at a
concentration of 70 µM. For FRET experiments, AF488-
labeled and AF594-labeled monomeric α-synuclein were
incubated together to a final concentration of 70 µM. Similar
to the aggregation of unlabeled α-synuclein, the reaction
was performed in the dark at 37 °C with constant agitation
at 200 rpm (same incubator as above) and aliquots were
withdrawn at specific time points.
Different time points of unlabeled α-synuclein aggrega-
tion reaction were characterized using a highly sensitive
single-molecule method termed SAVE (Single Aggregate
Visualization by Enhancement) imaging, which uses single-
molecule fluorescence microscopy to detect the benzothia-
zole salt thioflavin-T (ThT) (Supplementary Fig. 1). Upon
binding to β-sheet structures, ThT fluorescence increases
allowing individual aggregated species to be detected. From
2 h onwards, the number of diffraction limited fluorescent
puncta increases, which represents the emergence of oli-
gomers and at later time points (>24 h), fibrils as long as
5 µm are observed. For this study, we used time point 0 h
(no aggregates), 8 h (maximum number of oligomers
without the presence of fibrils) and 24 h [16](fibrils). The
kinetics of labeled α-synuclein reaction is different from the
unlabeled and the time point that maximizes the number of
oligomers is around 29 h and fibrils appear after 72 h.
Deuteration of PUFAs
Deuteration of PUFAs, deuterated polyunsaturated fatty
acids (D-PUFAs) were prepared as described previously
[25] and used as free acids. Non-deuterated PUFAs were
obtained from Sigma-Aldrich (99%; St. Louis, MO, USA).
Cells were pre-incubated with 10 μM D-PUFA in the cul-
turing media for 48 h prior to experiment and washed with
HEPES-buffered salt solution (HBSS) before experiments.
Live Imaging (fluorescence measurements)
Fluorescent indicators (fura-2 AM, dihydroethidium, C11-
BODIPY, SYTOX Green) were used to measure [Ca2+],
reactive oxygen species (ROS), and lipid peroxidation, and
cell death, respectively. The fluorescent data were collected
using a cooled camera device or a confocal microscope. For
fluorescence measurements with cooled camera device, data
were obtained on an epifluorescence inverted microscope
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equipped with a ×20 fluorite objective. For confocal
microscopy, images were obtained using an either Zeiss 710
or 880 (airy) vis CLSM equipped with a META detection
system and a ×40 oil immersion objective. Illumination
intensity was kept to a minimum (at 0.1–0.2% of laser
output) to avoid phototoxicity and the pinhole set to give an
optical slice of ~2 µm. All data presented were obtained
from at least three coverslips and 2–3 different inductions.
For measurements of [Ca2+]c, cells were loaded for 30min
at room temperature with 5 µM Fura-2 AM with 0.005%
pluronic acid in a HBSS composed of (mM): 156 NaCl, 3
KCl, 2MgSO4, 1.25 KH2PO4, 2 CaCl2, 10 Glucose, and 10
HEPES; pH adjusted to 7.35 with NaOH. [Ca2+]c was
monitored in single cells using excitation light provided by a
Xenon arc lamp, the beam passing through monochromator
centered sequentially at 340 and 380 nm (Cairn Research,
Kent, UK). Emitted fluorescence light was reflected through a
515 nm longpass filter to a cooled CCD camera (Retiga,
QImaging, Canada). All imaging data were collected and
analyzed using software from Andor (Belfast, UK). The Fura-
2 data have not been calibrated in terms of [Ca2+]c because of
the uncertainty arising from the use of different calibration
techniques. For Dihydroethidium (Het) we generated ratios of
the oxidized form (ethidium) excited at 530 nm and measured
using a 560 nm longpass filter and the reduced form with
excitation at 380 nm, measured between 415 and 470 nm.
To assess lipid peroxidation, cells were loaded with C11-
BODIPY (581/591, 2 μM, Molecular Probes) in HEPES-
buffered HBSS for 20 min prior to imaging and then excited
using the 488 and 565 nm laser and fluorescence measured
from 505 to 550 nm and above 580 nm (409 objective)
using a confocal microscopy. The intensely fluorescent
C11-BODIPY 581/591 fluorophore is an intrinsically lipo-
philic dye, which results in accumulation within mem-
branes. Upon oxidation of the polyunsaturated butadienyl
portion of the dye, there is a shift of the fluorescent emission
peak from 590 nm to 510 nm, and it remains lipophilic, thus
reflecting lipid peroxidation in membranes.
For SYTOX green (Molecular Probes), cells were loaded
with SYTOX green in HEPES-buffered HBSS for 15min.
High-throughput images were acquired using an Opera Phenix
High-Content Screening System (PerkinElmer). SYTOX
green staining was imaged by 488 nm and 405 nm for Hoechst
staining nuclei. Total 17–22 fields of images were taken per
wells. Then the percentage of cell death was quantified by the
ratio between the number of Sytox green-positive cells and the
total number of Hoechst expressing cells per image using a
Columbus StudioTM Cell Analysis Software.
To visualize cytoplasmic membrane, cells were washed
with HBSS and incubated with either CellMask deep red
Plasma membrane Stain (TheroFisherScientific, 5 μg/ml) for
5–10 min or CellBrite Blue (Biotium, 5 μM) for 30 min in
HBSS and live-cell imaging was performed.
Measuring α-synuclein aggregate-induced Ca2+
influx
To characterize aggregation in neurons derived from SNCA
x3, lysates and media were collected from both control and
SNCA x3. Cells were lysed mechanically without using a
lysis buffer. The lysates and media were collected in an
Eppendorf tube and centrifuged at 15,000 rpm for 15 min.
Supernatant was collected in a fresh Eppendorf tube and
kept in −80 until use.
For the membrane permeabilization assay, vesicles are
prepared as previously described [26]. Using this assay, it
has been previously shown α-synuclein oligomers disrupt
and permeabilise membranes [27, 28]. In brief, vesicles are
synthesized using Phospholipids 16:0–18:1 PC and bioti-
nylated lipids 18:1–12:0 Biotin PC (100:1) using freeze
thaw method and mean diameter is 200 nm. Vesicles of
oxidized lipid was made using oxPAPC (Oxidized 1-pal-
mitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine) and
18:1–12:0 Biotin PC. Each vesicle is filled with 100 μM Cal-
520 dye and immobilized in PLL-g-PEG-coated plasma
cleaned glass coverslips using biotin-neutravidin linkage.
The surrounding of the vesicles was filled with Ca2+ buffer.
In all, 50 µL of sample was incubated with the vesicles for
15 min and Ca2+ influx was quantitatively measured using a
homebuilt total internal reflection fluorescence microscope
based on an inverted Nikon Ti-2 microscope. In all, 488 nm
laser was focused back-focal plane of the ×100, 1.49NA oil
immersion objective lens used to excite the Cal-520 dye.
The fluorescence signal was collected by the same objective
and magnified 1.5 times. Then the emission light was pas-
sed through a longpass filter (BLP01-488R-25) and a band
pass filter (FF01-520/44-25) before imaged in EmCCD
camera. To check if the aggregate present in SNCA x3
media and lysates are composed of α-synuclein, we have
used previously reported method to determine the compo-
sition of the aggregates [29, 30]. Media was incubated with
Anti-Alpha-synuclein (phospho S129) antibody (Abcam
ab51253), for 30 min and then added to the coverslips
containing dye filled vesicles. Statistical significance test
was performed using two sample unpaired t test.
Electrophysiology
Single-channel electrophysiology in living neurons
Patch-clamp recordings of α-synuclein channels over-
expressed in iPSC-derived neurons were performed in perfu-
sion solution containing: 124mM NaCl, 3mM KCl, 26mM
NaHCO3, 1.25mM NaH2PO4, 10mM D-glucose, 2 mM CaCl2,
2 mM MgCl2, bubbled with 95:5 O2/CO2 (pH 7.4). To isolate
response of α-synuclein channels we added to external solu-
tion 50 µM D-APV, 10 µM NBQX, 100 µM picrotoxin and 1 µM
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strychnine. Outside-out patches were excised from cell soma
and held at −70mV membrane potential. Intrapipette solution
contained 117.5 mM Cs-gluconate, 17.5 mM CsCl, 10mM
KOH-HEPES, 10mM BAPTA, 8mM NaCl, 5mM QX-314,
2 mM Mg-ATP, 0.3 mM GTP. As a control, we performed
recordings from outside-out patches pulled from iPSC-derived
neurons received from healthy volunteers.
Recordings were performed at 33–35 °C using
Multiclamp-700B amplifier, in whole-cell mode; signals
were digitized at 10 kHz. Recording electrodes were pulled
from the thick-wall borosilicate glass capillaries and fire-
polished to 5–7MOhm resistance.
In human stem cell-derived neurons, to calculate and
visualize amplitude characteristic for ion channel openings,
we constructed all-points histograms with 0.1 pA bin, and
fitted them with a double-Gaussian function:
F ¼ p1e
 nm1ð Þ
2
2σ2
1
σ1
ffiffiffiffiffi
2π
p þ p2e
 nm2ð Þ
2
2σ2
2
σ2
ffiffiffiffiffi
2π
p ;
where m1 and m2 are the mode values of Gaussians, σ1 and
σ2 are the standard deviations of corresponding modes, n is
the value of electrical current, and p1 and p2 are the fitting
constants.
With this approach the mode value for the open state was
fitted as 2.17 pA.
Channel activity in liposomes
Giant liposomes were prepared as described previously
[31]. In brief, liposomes were formed by sonication of lipid
(type IV-S soybean L-phosphatidylcholine; Sigma-Aldrich)
in water. Liposomes (600 µg lipid) were mixed with 5 mM
HEPES, pH 7.4 (50 µl volume) and with protein sample
(5 µl), and dotted on a glass slide. Samples were dehydrated
(3 h) and rehydrated overnight with 150 mM KCl, 5 mM
Hepes, pH 7.4, at 4 C. Patch-clamp procedures and analysis
used were described previously [18]. Membrane patches
were excised from liposomes after formation of a giga-seal
using micropipettes with ~0.4 m diameter tips and resis-
tances of 10–20 ΩM at room temperature. Voltage clamp
was performed with the excised configuration of the patch-
clamp technique using an Elements eONE patch-clamp
amplifier in the inside-out mode. Voltages are reported as
pipette potentials. Current traces were processed using
pCLAMP software. Traces for figure and all-points histo-
grams were prepared using Origin 9.
ELISA assay
To measure the concentration of oligomeric α-synuclein, cell
lysate were mechanically collected from CTRL and SNCA x3
neurons. α-synuclein oligomer was analyzed using human
α-synuclein oligomer (non A4 component of amyloid pre-
cursor) ELISA kit (CSB-E18033h, Generon) and then nor-
malized by total protein per well using Pierce BCA Protein
Assay Kit (23225, ThermoFisherScientific).
Aptamer staining
Cells were permeabilized with 0.25% Triton X 100 and
blocked with 10% Normal Goat Serum for 20 min followed
by another 3 h with 0.1% Triton X—100 and 10% Normal
Goat Serum. Then cells were incubated overnight with
0.5 µM ATTO-425 labeled Aptamer [32]. Cells were washed
three times with PBS and imaged.
Immunohistochemistry
Cells (cultured in ibidi chamber) were fixed in 4% paraf-
ormaldehyde and permeabilized with 0.2% Triton-100. In all,
5% bovine serum albumin (BSA) was used to block non-
specific binding. Cells were incubated with primary antibody
for 1 hr at room temperature and washed three times with 5%
BSA. Cells were incubated with secondary antibody for 1 hr at
room temperature. Cells were imaged with PBS after three
times wash. Hoechst was added in the second wash if
required.
Statistical analysis
Statistical analysis (unpaired two sample t test or one-way
analysis of variance, P value is set at 0.05) and curve fitting
were performed using Origin 2018 (Microcal Software Inc.,
Northampton, MA) software. Results are expressed as
means ± standard error of the mean (SEM). N= number of
inductions and n= number of cells, if not stated otherwise.
Sample sizes for experiments were selected to capture
adequate technical variation (number of cells; numbers of
fields of view; number of coverslips) and biological varia-
tion (numbers of independent inductions; numbers of
clones/patient line). Variance within each group was esti-
mated using a F-statistics (sum of squares). All experiments
were repeated minimum three times. All experiments were
performed in a count balance manner and data were col-
lected and analyzed without bias.
Results
Human iPS derived neurons with increased α-
synuclein exhibit abnormal calcium signaling
Differentiation of control iPSCs (control, or CTRL), SNCA
triplication iPSCs (SNCA x3), and isogenic control iPSCs,
into cortical neurons was performed. The SNCA x3
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mutation is a gene triplication, leading to a doubling of α-
synuclein protein expression [20]. We generated enriched
populations of neurons from both control and SNCA x3
mutant lines, with a small proportion of glial-like cells
(Fig. 1a, b). Immunocytochemistry (α-synuclein Ab
MJFR1, Abcam), demonstrated elevated α-synuclein
Fig. 1 Abnormal calcium signaling in iPSC-derived neurons with
SNCA x3. a Protocol to differentiate iPSC to cortical neurons. b The
majority of cells are Tuj 1 (and not GFAP-positive) in both control
(CTRL) and mutant (SNCA x3) lines, (a) Representative images with
Tuj 1 (neuronal marker, red) and GFAP (astrocytic marker, green),
DAPI (total cell number, blue). (b) Percentage cell proportion
expressing Tuj 1 or GFAP, N= 3 CTRL & SNCA. c (a) Repre-
sentative tracers of cytosolic calcium rise in response to 5 µM gluta-
mate not to ATP. (b) Percent cell population responding to either 5 µM
glutamate or 100 µM ATP, N= 3 CTRL & SNCA. (c) Application of 5
µM glutamate induced a rise in cytosolic calcium, which was sig-
nificantly higher in SNCA x3 neurons compared with control neurons,
N= 3 CTRL & SNCA. d (a) 5 µM glutamate induces calcium
signaling. (b) Depolarization of cells with 50 mM KCl results in
opening of voltage-dependent calcium channels and a cytosolic cal-
cium signal, which was significantly higher in SNCA x3 neurons
compared with control. (c) Stimulation of the P2Y receptors with 100
µM ATP induced a cytosolic calcium signal that was significantly
lower in the SNCA x3 cells compared with control. (d) Histogram
demonstrates the mean values of the calcium signals induced by glu-
tamate, KCl and ATP (mean ± SEM), N= 3 per condition for CTRL &
SNCA x3. e (a) Registered events of spiking activity in individual
control and SNCA triplication cells (spikes are marked with arrows,
orange-CTRL, teal-SNCA x3). (b) No. of events per cell*min*1000
(mean ± SEM). n= 180 CTRL and 125 SNCA x3 cells. *P < 0.05,
**P < 0.001, ***P < 0.0001.
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protein expression in SNCA x3 cells (Supplementary Fig. 2
Aa & b).
We investigated whether physiological calcium respon-
ses are altered by increased expression of α-synuclein. We
stimulated iPSC-derived neurons with physiological con-
centrations of glutamate (5 µM) and KCl (50 mM), which
induces opening of potential-sensitive Ca2+ channels that
are specific for neurons. We then stimulated a calcium
signal with 100 µM ATP, which induces activation of P2Y
receptors [33]. There is no significant difference in the
proportion of cells responding to either glutamate (neurons)
or ATP stimuli (glia-like) in CTRL, SNCA x3 and Iso-
CTRL (Fig. 1c(a, b)). Stimulation of neurons with 5 µM
glutamate induces a significantly higher signal in SNCA x3
cells compared with both isogenic control and healthy
control cells (CTRL: 0.65 ± 0.04, n= 96, SNCA x3: 1.2 ±
0.1, n= 99; p < 0.001, Fig. 1cc, d(a, d)). The physiological
[Ca2+]c response to 50 mM KCl was also higher in SNCA x3
iPSC-derived neurons (0.29 ± 0.01, n= 101) when com-
pared with control neurons (1.01 ± 0.039, n= 114; p <
0.001; Fig. 1d(b, d)). Stimulation with 100 µM ATP leads to
an increase in [Ca2+]c in glial-like cells, but not in neurons.
This [Ca2+]c response was significantly lower in glial-like
cells with SNCA x3 when compared with control cells
(0.49 ± 0.03, n= 68 in CTRL; p < 0.001; Fig. 1d(c, d)). We
also detected an impairment of intracellular calcium
homeostasis in SNCA x3 showing re-distribution of Ca2+
stores, and depletion of ER calcium, and increase in mito-
chondrial calcium (Supplementary Fig. 3).
One of the major characteristics of mature neurons is
their spontaneous calcium activity. Spontaneous calcium
transients were observed in all iPSC-derived cortical neu-
rons (Fig. 1ea), with no significant difference in the
amplitude of these transients (Fig. 1eb) between CTRL and
SNCA x3.
Increased expression of α-synuclein in a hES model
demonstrates altered calcium signaling
To test the effect specifically of SNCA expression in neu-
rons, we utilized a model of transgenic human stem cell-
derived neurons engineered to express SNCA at control or
high levels [18], on an isogenic background. Both control
and SNCA o/e cells displayed a native-like membrane
potential of 61 ± 5 mV (n= 4), characteristic for neurons,
and generated action potentials of classical shape in
response to current injection. Action potentials in SNCA o/e
cells were generated with significantly lower frequency: 4.2
± 1.3 Hz vs. 18.7 ± 3.4 Hz in control, P < 0.01, n= 4, 7,
Student’s t test. In all, 1 µM of tetrodotoxin added into the
perfusion solution fully suppressed action potential gen-
eration, revealing the presence of voltage-gated sodium
channels in the tested cells (Supplementary Fig. 4 Aa & b).
To test the calcium response to physiological stimuli, we
applied glutamate (10 µM), which induces a typical calcium
transient in control neurons, and SNCA o/e (Supplementary
Fig. 4 Ba & d, CTRL; n= 47 cells, SNCA x3; n= 32 cells).
In agreement with previous results, glutamate-induced cal-
cium signal in SNCA o/e was significantly higher than those
found in CTRL (signal rose to 1.3 ± 0.24 Fura-2 ratio
compared with 0.7 ± 0.08 Fura-2 ratio, p < 0.05). More than
60% cells demonstrated typical response to plasma mem-
brane depolarization with opening of voltage-gated calcium
channels (Supplementary Fig. 4Bc & d). Again, SNCA o/e
cells had significantly higher calcium responses to 50 mM
KCl (Supplementary Fig. 4Bc & d, CTRL; 0.92 ± 0.1 Fura-
2 ratio, n= 39, SNCA x3; compared with 0.61 ± 0.08 Fura-
2 ratio in control, n= 38 cells; p < 0.05).
Application of 100 µM ATP stimulates calcium signaling
via P2Y receptors, expressed predominantly in astrocytes.
Approximately 40% of cells in the field demonstrated a
calcium response to application of ATP, and SNCA o/e
cells demonstrated a higher ATP-induced calcium signal
than control cells (Supplementary Fig. 4Bb & d, CTRL;
1.21 ± 2.2 Fura-2 ratio, n= 37, SNCA x3; compared with
control 0.97 ± 0.07 Fura-2 ratio, n= 47 cells; p < 0.05).
Alpha-synuclein aggregates disrupt membranes and
alter membrane conductance
We investigated how α-synuclein aggregates disrupt mem-
branes and induce ion fluxes. Using a ATTO-425-labeled
Aptamer that recognizes oligomeric aggregates of α-
synuclein [32], we confirmed the increase in aggregates in
the SNCA x3 cells, demonstrated both by intensity, and area
of cell occupied by aggregates. (Fig. 2a). This aptamer,
using super resolution microscopy (ADPAINT) has
demonstrated an increase in larger aggregates in SNCA x3
neurons [32]. We performed an oligomer ELISA to measure
the soluble aggregates in the SNCA x3 and CTRL cell
lysates (Supplementary Fig. 5), and demonstrated a selec-
tive increase in oligomers in the SNCA x3 neurons (Sup-
plementary Fig. 5b).
Aggregates formed in the SNCA x3 cells, and secreted in
the media, are capable of permeabilising membranes, and
inducing ion fluxes. Using a single vesicle assay, we
demonstrated that application of SNCA x3 lysates and
media induced calcium influx across liposomes. This cal-
cium influx was blocked after incubation of SNCA x3
lysates and media (25× dilution) with Anti- α-synuclein
(phospho S129) antibody (see Fig. 2ba for experimental
paradigm). Therefore, both secreted oligomers in the
extracellular space of SNCA x3, as well as internally gen-
erated oligomers possess a structural conformation that can
interact with, and disrupt, membranes (Fig. 1b(b, c)) to
induce calcium fluxes.
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Fig. 2 α-synuclein aggregates disrupt membranes. a iPSC-derived
cortical neurons from patients carrying 3x SNCA exhibit aggregates.
(a–c) Aptamer expression level (both area and intensity) is higher in
iPSC-derived neurons with SNCA x3, N= 3 CTRL & SNCA x3. b (a)
Illustration of membrane permeabilization assay by measuring Ca2+
influx in vesicles. (b, c) Cell lysates and media from SNCA x3 induce
higher level of permeabilization than control, prevented by antibody
(phospho S129) binding of α-synuclein aggregates, N= 3 CTRL &
SNCA. c (a) Single-channel activity of α-synuclein in the membrane
of iPSC-derived neurons. Top: control recording from outside-out
patch pulled from control neurons. Middle: recording from outside-out
patch pulled from SNCA x3 neurons. Bottom: extended section of the
medium trace marked by the dashed lines. Vertical scale bar applying
to all three traces; horizontal (time) scale bar apply to the top and
medium trace. (b) All-points amplitude histogram of channel openings
in the membrane of iPSC-derived neurons with SNCA x3, fitted with
double-Gaussian function, N= 3 CTRL & SNCA. d (a) Single-
channel activity of α-synuclein in the membrane of giant liposomes
consisting of lipids. Channels open followed by partial inactivation to
a stable subconductance level (open 1). After switch to –20 mV the
channels open to a higher conductance state (open 2). (b) Current
amplitude histogram of the α-synuclein channel activity in giant
liposome patch represented in (a). *P < 0.05, **P < 0.001, ***P <
0.0001.
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To test the effect of increased endogenous α-synuclein
on the membrane conductance of neurons, we performed
patch-clamp recordings from outside-out membrane patches
in a voltage clamp mode. To isolate the response solely of
channels formed by α-synuclein aggregates, we added to the
external solution 50 µM D-APV, 10 µM NBQX, 100 µM
picrotoxin and 1 µM strychnine. We registered single-
channel openings in patches excised from iPSC-derived
neurons with SNCA x3 (channel conductance 189 ± 26 pS,
n= 5), whereas no single-channel activity was observed in
control neuronal cultures when a similar cocktail of ion
channel blockers was applied (Fig. 2ca). However, we
managed to detect activity only in a small fraction of SNCA
x3 neurons (Fig. 2ca); five successful recordings out of 29
outside-out patches (each patch was pulled from a separate
cell). To calculate the amplitude of the ion channel opening,
all point histograms were constructed and fitted to a double-
Gaussian function. The mode value for the open state was
fitted at 2.17 pA (Fig. 2cb). These data suggest the presence
of channel formation on the plasmalemmal membrane of
neurons with high levels of α-synuclein, independent on
any known ion channels.
We investigated the effect of α-syn aggregates on the ion
permeability of membranes, using patch-clamp of giant
liposomes exposed to recombinant α-synuclein oligomers.
We detected single-channel activity induced by oligomers of
α-syn, but not monomers (Fig. 2d(a, b)), and these channels
had multiple conductance levels, with opening and partial
inactivity to stable subconductance at a constant voltage,
followed by higher conductance states induced at −20mV.
Increased expression of α-synuclein leads to
generation of reactive oxygen species and
membrane oxidation
We have reported that oligomeric α-synuclein drives the
aberrant generation of intracellular superoxide and hydro-
gen peroxide, and the depletion of antioxidants [17, 34].
Basal superoxide production is increased in the SNCA x3
iPSC-derived neurons [17] and addition of recombinant
oligomers further increased superoxide production (CTRL;
175 ± 11.9 %, N= 4, p < 0.0001, SNCA x3; 158.3 % to
343.0 ± 37.3 %, N= 4, p < 0.0001, Fig. 3a). Consistently,
hES cells with SNCA o/e also produce abnormal levels of
superoxide (Supplementary Fig. 6). SNCA x3 iPSC-derived
neurons also exhibit an increase in basal lipid peroxidation
from 0.161 ± 0.004 to 0.241 ± 0.007, both N= 4, p <
0.0001; addition of oligomers to control cells increased lipid
Fig. 3 ROS production and lipid peroxidation induced by α-
synuclein in neurons. a, b SNCA x3 neurons are vulnerable to
exogenously applied α-synuclein oligomers. (a) Rate of ROS pro-
duction in iPSC-derived SNCA x3 neurons is higher than in control
neurons. (N= 3 CTRL, SNCA & D4-Lnn-treated SNCA). (a) Basal
lipid peroxidation rate in iPSC-derived neurons with α-synuclein 3x is
higher than the control neurons, but could be restored through pre-
treatment with D4-Linolenic acid (D4-Lnn) in SNCA x3 neurons,
which also prevented oligomer-induced lipid peroxidation (N= 3
CTRL, SNCA & D4-Lnn-treated SNCA). (b) Representative traces of
(a). c Characterization of α-synuclein—membrane interactions. (a)
Representative images of exogenous oligomeric α-synuclein uptake
(AF488 fluorescence, green) into the cytoplasm (plasmic membranes
are labeled with CellMask Depp Red dye; magenta color) in control
neurons with or without Trolox treatment. Oligomer uptake was sig-
nificantly reduced when membrane oxidation was inhibited by Trolox,
N= 5 basal & Trolox. (b) Trolox inhibits uptake of aggregate forms of
α-synuclein. d Calcium influx in the membrane permeabilisation assay
was increased when vesicles composed of oxidized lipids were gen-
erated. 16:0—20:4 PC non-oxidized membrane. Ox PAPC oxidized
membrane, N= 3 non & oxidized membrane. *P < 0.05, **P < 0.001,
***P < 0.0001.
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peroxidation to 0.456 ± 0.003, N= 4, p < 0.0001; similarly,
addition of oligomers to SNCA x3 increased lipid perox-
idation to 0.408 ± 0.005, N= 4, p < 0.0001 (Fig. 3b).
Isotopic reinforced polyunsaturated fatty acids (D-
PUFAs) incorporate into lipid membranes and render them
resistant to the ROS initiated chain reaction of lipid per-
oxidation. We pre-treated cells with 10 µM deuterated
Linolenic acid (D4-Lnn), which prevented oligomer-
induced lipid peroxidation, and restored basal levels of
lipid peroxidation in the SNCA x3 cells (Fig. 3b). Therefore,
recombinant oligomers, as well as oligomers generated in
the SNCA x3 cells, induce oxidation of PUFAs, which can
be modulated by the use of deuterated species.
Lipid peroxidation influences the physical
interaction of aggregates and membranes
α-synuclein- membrane interactions in cells are transient and
difficult to capture. Membrane binding to the plasma
membrane is a prerequisite prior to internalization of α-
synuclein into the cell [35]. Labeled oligomers (oligomers
generated from AF488 monomeric α-synuclein) were
applied to cells loaded with either a cell mask dye, or a
membrane dye. Internalization of fluorescently labeled
monomer and oligomer is demonstrated in Fig. 3ca and
Supplementary Fig. 7Aa. Vitamin E is a tocopherol that
inhibits lipid peroxidation by scavenging lipid peroxyl
radicals. We pre-incubated cells with Trolox, a water soluble
analog of α-tocopherol which is able to incorporate into both
water and lipid compartments, reduced the α-synuclein
accumulation in the cell (as demonstrated by reduced AF488
area/cell, Fig. 3cb and Supplementary Fig. 7Ab.
Next, we tested the effect of membrane oxidation on
insertion of aggregates into membranes utilizing the mem-
brane Permeabilization assay (described in Fig. 2ca). Using
vesicles generated from oxidized lipids, there is higher
calcium influx on exposure to the same concentration of α-
synuclein oligomers, compared with control lipid vesicle
(Fig. 3d).
Together, these data suggest that under conditions of
membrane oxidation, there is an enhanced membrane bind-
ing of oligomers of α-synuclein, allowing ion fluxes across
the membrane, as well as entry into the cell. This interaction
is reduced in cells with non-oxidized membranes.
Lipid peroxidation drives α-synuclein-induced
abnormal calcium signaling
Next we tested whether the α-synuclein-induced calcium
signaling is affected by lipid peroxidation. We demon-
strated abnormal glutamate-induced calcium signaling in
SNCA x3 neurons (Fig. 4ab, bb). Pre-incubation of cells for
24 h with D4-Lnn restored the glutamate-induced calcium
signaling back to control levels (from 2.50 ± 0.27, N= 7,
n= 100, Fig. 4ab, da to 1.43 ± 0.25, n= 7, N= 7, p=
0.0113, Fig. 4ac, da after the use of D4-Lnn). Pre-
incubation of cells with D4-Lnn interestingly abolished
the KCL-induced opening of voltage-dependent calcium
channels (from 1.65 ± 0.22, N= 9, n= 114, Fig. 4ab, db to
0.30 ± 0.09, N= 5, n= 165, p= 0.0009, Fig. 4a(b, c), db).
ATP-induced calcium signal is significantly smaller in the
SNCA x3 cells compared with control (CTRL: 1.92 ± 0.27,
N= 4, n= 165, SNCA x3: 0.75 ± 0.11, N= 4, n= 114,
p= 0.0062, Fig. 4b(a, c)). This was also restored by the pre-
incubation of D4-Lnn (1.70 ± 0.30, N= 4, n= 120, p=
0.0251, Fig. 4bc, dc).
We previously showed that dopamine induces calcium
signaling through dopamine receptor independent mechan-
isms [36, 37], and this includes (i) the opening of voltage-
dependent calcium channels following dopamine uptake
and depolarization of the plasmalemmal membrane and (ii)
dopamine-induced lipid peroxidation and activation of
phospholipase C and release of calcium from ER stores.
Application of two stimuli of dopamine induces a typical
calcium response in control cells [37]. However, SNCA x3
cells exhibited a significantly higher calcium response to the
second stimulus of dopamine compared with control cells
(SNCA x3: from 0.61 ± 0.09, n= 160, N= 8, n= 160 to
1.89 ± 0.21, N= 6, n= 136, p= 0.0001; Fig. 4c(a, b)). The
calcium response to dopamine in SNCA x3 was fully
abolished when cells were pre-treated with D4-Lnn (0.16 ±
0.08, N= 4, n= 148, p= 0.0002; Fig. 4cc, dd). Complete
prevention of the dopamine-induced calcium response by D-
PUFAs is likely to be due to blockade of both insertion of
channels into the membranes (in keeping with depolarizing
stimuli), as well as blockade of the PLC/IP3 response.
These data suggest that the incorporation of α-synuclein as
a channel into the plasma membrane occurs when the
PUFAs in membranes have undergone lipid peroxidation.
Non-oxidizable PUFAs lead to membranes that are resistant
to the insertion of oligomers and their channel-forming
activity, and do not demonstrate glutamate/dopamine-
induced calcium deregulation.
Oligomer-induced toxicity is dependent on iron and
lipid peroxidation
SNCA x3 cells exhibit reduced cell viability compared with
CTRL over time in culture, shown in Figure. 5a(a, b). We
tested the sensitivity to ferroptosis of our iPSC-derived
synucleinopathy model using the ferroptosis inducer, era-
stin, and we show that erastin induces a dose-dependent
increase in cell death, shown in Fig. 5b. Oligomer-induced
oxidative stress is dependent on transition metal ions [17].
We tested the effects of metal ion chelator (Desferoxamine,
DFO), inhibitor of lipid peroxidation (D4-Lnn), and a
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ferroptosis inhibitor (Ferrostatin-1) on cell death in synu-
cleinopathy [38]. Application of oligomers but not mono-
mers, induced cell death in control (Fig. 5c(a, b)) neurons
and SNCA x3 (Fig. 5c(a, c)) neurons. Application of three
different ferroptosis inhibitors, deuterated PUFAs, iron
chelator DFO (Sigma), and ferrostatin-1 (Ferr-1, Sigma, Cat
No. SML0583) each significantly reduced oligomer-
induced cell death back to basal levels in control cells
(Fig. 5c(a, b) and in SNCA x3 cells (Fig. 5c(a, c)). Taken
together these data suggest that α-synuclein aggregates may
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induce ferroptosis, and that inhibitors of ferroptosis prevent
α-synuclein-induced cell death, and inducers of ferroptosis
exacerbate cell death.
Discussion
Ferroptosis [39] describes a form of non-apoptotic regulated
cell death occurring as a consequence of iron-dependent
accumulation of lethal lipid peroxidation. Ferroptosis
is characterized by cell swelling (oncosis), altered mito-
chondrial morphology [40], and unique features of lipid
peroxidation with preferential oxidation of phosphatidy-
lethanolamine [41]. Suppression of the formation of oxi-
dized lipids halts cell death. The downstream pathways
whereby lipid peroxidation leads to cell dysfunction or
death are not fully established, but are proposed to include
loss of membrane integrity, opening of pores and loss of
ionic homeostasis, formation of free radicals that inactivates
membrane-embedded proteins required for cell viability
[42]. The major criteria for determining ferroptosis are the
ability to suppress death by iron chelators, lipophilic anti-
oxidants, inhibition of lipid peroxidation, and depletion of
lipid peroxidation.
In neurodegeneration [43], a number of ferroptosis
features are commonly reported, in particular depletion of
glutathione, accumulation of lipid peroxidation products,
excess extracellular glutamate, decreased cortical GPX4,
increased lipoxygenase (LOX) activity, protection from
lipophilic antioxidant vitamin E (in AD), protection from
iron chelators [44], and protection from pioglitazone, an
ACSL4 inhibitor [45]. In addition, brain iron levels rise in
during aging and neurodegenerative disease, which can be
detected in living people [46] and in postmortem tissue.
However, lipid peroxidation and ferroptosis has not
been previously investigated in synucleinopathy models
of PD [47].
Here, we study the complex intersection between protein
aggregation, calcium deregulation and lipid peroxidation
(Fig. 6). We have demonstrated that abnormal calcium
fluxes, as well as abnormal intracellular stores, is an
important biological property of specific α-synuclein oli-
gomers, when applied exogenously to cell systems [13, 48].
In this study, we demonstrate that increased endogenous
levels of α-synuclein oligomers, are associated with high
cytosolic calcium influx in response to activation of gluta-
mate receptors or changes in plasmalemmal membrane
potential. This could be attributable either to high expres-
sion of potential-sensitive calcium channels or increased
activation of glutamate receptors. Our data suggest an
increased presence of potential-sensitive channels on the
plasmalemmal membrane of the human neurons with high
levels of oligomeric α-synuclein. Such channels are known
to be formed by the effect of α-synuclein β-sheet-rich oli-
gomers on membranes [13]. Notably, solution and solid-
state NMR methods have confirmed that the exogenously
applied oligomers used in this study, result in maximal
membrane disruption by allowing the structured oligomer
core to insert into the lipid bilayer and disrupt the integrity
[14]. In our study, oligomers induce ion fluxes in the
absence of the NMDA receptor components in artificial
systems (liposomes), and additionally oligomers induce
channel formation in the presence of NMDA blockade in
outside-out patches in cells, Taken together, this supports
the hypothesis that the α-synuclein oligomeric species alone
are able to insert into membranes (in particular oxidized
membranes), upon depolarizing stimuli, leading to a
voltage-dependent increase in cytosolic calcium influx in
response to glutamate, KCl, and dopamine.
The second key feature is the ability for oligomeric α-
synuclein, both when applied exogenously or when gener-
ated endogenously, to induce the production of superoxide
and hydrogen peroxide [17] and lipid peroxidation [49].
Notably, the mechanism of oligomer-induced ROS pro-
duction and lipid peroxidation is iron-dependent, and non-
enzymatic, likely dependent on the Fenton reaction [17, 18].
As protein aggregates interact with, and disrupt, lipid
membranes, we sought to modulate this interaction through
altering membrane properties by their oxidation state [50].
Lipidomics has previously been used to demonstrate that
PUFAs are the most susceptible lipids in the course of
ferroptosis [41], and that preventing peroxidation by sup-
plementing cells with PUFAs deuterated at the susceptible
bis-allcylic carbon suppresses ferroptosis [51]. Based on
this, supplementation of media with deuterated D4-linolenic
acid has shown to prevent lipid peroxidation [49], and also
to prevent ferroptosis [51]. We show that supplementation
of the media with deuterated PUFAs is able to prevent
oligomer-induced lipid peroxidation. We further demon-
strated that in the absence of lipid peroxidation, the α-
Fig. 4 Prevention of lipid peroxidation restores calcium dysregu-
lation in SNCA x3 neurons. a Representative traces showing deut-
erated PUFAs restore abnormal glutamate-induced calcium signaling
or KCl-induced depolarization in SNCA x3 neurons (b) to control
levels (c). b ATP-induced calcium signal is smaller in the SNCA x3
cells (b) compared with control (a). This was also restored by pre-
incubation of the cells with D-PUFAs (c). c Double bolus of dopamine
(50 µM) in SNCA x3 neurons evoked dysregulated calcium signal (b)
in comparison with control response (a). (c) Pre-incubation of the
SNCA x3 cells with D4-Lnn prevents dopamine-induced cytosolic
calcium signals. d Quantification histograms depicting the preventive
effect of deuterated PUFAs (D4-Lnn) on the calcium response to
application of glutamate (a, N= 4 CTRL, N= 5 SNCA, N= 7 D4-Lnn
treated SNCA), KCl (b, N= 5 CTRL, N= 7 SNCA, N= 4 D4-Lnn
treated SNCA), ATP (c N= 4 CTRL, SNCA & D4-Lnn treated
SNCA) or dopamine (d, N= 5 CTRL, N= 3 & 4 SNCA, N= 3 D4-
Lnn-treated SNCA) in both control and iPSC-derived neurons with
SNCA x3. *P < 0.05, **P < 0.001, ***P < 0.0001.
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synuclein-induced calcium dysregulation is also abolished,
and physiological calcium signaling is restored. This effect
is true for glutamate-induced, KCL-induced and also
dopamine-induced calcium signaling, which induces both a
calcium influx [36], as well as generates ROS [37]. We
therefore confirmed that lipid peroxidation allows mem-
branes to be more susceptible to aggregates inserting into
them and disruption of ion fluxes. Stabilization of the oxi-
dation state of the membrane prevents additional oligomeric
channel insertion, and reduces ion fluxes across the
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membrane. Our hypothesis is that the oxidation state of the
membrane confers its susceptibility to a physical and
functional interaction with β-sheet-rich oligomeric proteins.
It is possible that oxidized lipids recruit more oligomers to
the membrane, or that any individual rare oligomer event
results in greater disruption of the membrane and more
calcium influx, and it is challenging to distinguish these two
possibilities [52].
Iron chelators, D-PUFAs, and ferrostatin were all able to
suppress cell death induced by toxic oligomeric α-synu-
clein, or by dopamine in neurons. Inhibition of toxicity
using reduction of iron, suppression of lipid peroxidation,
and ferrostatin meets the basic criteria set out for the defi-
nition of ferroptosis [53], and therefore we raise the
hypothesis that α-synuclein may contribute to cell death by
this pathway, whereas recognizing that other forms of
apoptosis and necrosis also co-exist. The co-dependence of
protein aggregation, membrane damage and oxidative stress
in ferroptosis in neurodegeneration may underlie why
models based on a single factor alone (e.g., GPX4 deletion)
do not exhibit neurodegeneration [54].
Cellular aging, dopamine and α-synuclein oligomers
place the cell in a state of aberrant ROS production and
glutathione depletion, resulting in oxidative stress with lipid
peroxidation. Oxidation of specific PUFAs, leads to the
insertion of α-synuclein oligomers into the membrane
forming channels that open in response to depolarization of
the plasma membrane. This renders neurons vulnerable to
physiological calcium signaling and exposes them to high
levels of cytosolic calcium fluxes that may cause excito-
toxicity and cell death. At least part of the α-synuclein
aggregate-induced cell death is related to ferroptosis in
which the iron-dependent accumulation of lipid
peroxidation has an important role in the demise of neurons.
While in cellular models, targeting lipid peroxidation spe-
cifically using deuterated PUFAs, is a useful tool to
demonstrate the contribution of lipid oxidation to calcium
fluxes, its direct application to patients may be hindered by
the important physiological roles that lipid oxidation also
has in neuronal function. Nonetheless, modulation of lipid
peroxidation or ferroptosis may represent new potential
therapeutic approaches for PD.
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